CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm

In spite of consistent progress at the level of basic research and of clinical treatment, acute myeloid leukemia (AML) still represents an unmet clinical need for adult and pediatric patients. To improve the outcomes of these patients, it is necessary to identify new therapeutic targets. IL3RA (CD12...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelosi, Elvira, Castelli, Germana, Testa, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917129/
https://www.ncbi.nlm.nih.gov/pubmed/36769040
http://dx.doi.org/10.3390/ijms24032718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917129/
https://www.ncbi.nlm.nih.gov/pubmed/36769040
http://dx.doi.org/10.3390/ijms24032718

Ejemplares similares